| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/12/2007 | EP1752452A9 Propane-1,3-dione derivative or its salt |
| 12/12/2007 | EP1532250B1 Fcyriia transgenic animal model for autoimmune disease |
| 12/12/2007 | EP1505976B1 Synergistic combination of an opioid analgesic and a nsaid |
| 12/12/2007 | EP1500656B1 Biguanide derivatives and their use as antidiabetic drugs |
| 12/12/2007 | EP1496880A4 SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-kB INHIBITORS AND ANTI-NEOPLASTIC AGENTS |
| 12/12/2007 | EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
| 12/12/2007 | EP1470120B1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives |
| 12/12/2007 | EP1355668B1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 12/12/2007 | EP1276738B1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 12/12/2007 | EP1237859B1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 12/12/2007 | EP1148779B1 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 12/12/2007 | EP1144454B1 Modified peptides as therapeutic agents |
| 12/12/2007 | EP1143943B1 USE OF p53 INHIBITORS FOR THE TREATMENT OF SIDE EFFECTS OF CANCER THERAPY |
| 12/12/2007 | EP0932606B1 Inhibitors of prenyl transferases |
| 12/12/2007 | EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use |
| 12/12/2007 | CN101087605A Indolidone derivatives for the treatment or prevention of fibrotic diseases |
| 12/12/2007 | CN101087604A Medicaments for the treatment or prevention of fibrotic diseases |
| 12/12/2007 | CN101085806A Synthetic way and use of product thereof |
| 12/12/2007 | CN101085802A Method for preparing Notoginsen triterpenes |
| 12/12/2007 | CN101085759A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 12/12/2007 | CN101085756A Endothelin antagonist |
| 12/12/2007 | CN101085356A Non-virogene transfection carrier, complex particles of the same and plasmid DNA, preparing method and using method |
| 12/12/2007 | CN101085175A Chinese medicinal herb with toxin-expelling, sweat-removing and algidity-expelling function |
| 12/12/2007 | CN101084928A Volatile aromatic refrigerant refreshing agent and preparation method |
| 12/12/2007 | CN101084924A Method for preparing goat's horn extraction |
| 12/12/2007 | CN100354426C Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 12/12/2007 | CN100354307C NOGO receptor-mediated blockade of axonal growth |
| 12/12/2007 | CN100354277C 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 12/12/2007 | CN100354273C Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 12/12/2007 | CN100354267C Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds |
| 12/12/2007 | CN100354265C Pharmaceutical compounds |
| 12/12/2007 | CN100354263C Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles |
| 12/12/2007 | CN100353950C Medicine Rb2 used for thrombolysis, anti reperfusion injury, improving microcirculation and repairing injured tissue and its prepn. method |
| 12/12/2007 | CN100353937C Agents for fattening animals |
| 12/12/2007 | CN100353933C Instant oral medincinal preparation |
| 12/11/2007 | US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/11/2007 | US7307150 Dextran-hemoglobin conjugates as blood substitutes |
| 12/11/2007 | US7307102 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity |
| 12/11/2007 | US7307101 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow |
| 12/11/2007 | US7307098 Indole derivatives and drugs containing the same |
| 12/11/2007 | US7307096 For intraocular pressure lowering action; for therapy and prophylaxis |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction |
| 12/11/2007 | US7307075 Tetrahydroquinoline analogues as muscarinic agonists |
| 12/11/2007 | US7307069 Inflammatory diseases and cancers; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 12/11/2007 | US7306950 Composition and use of substances for stabilising amino acids containing sulphur |
| 12/11/2007 | US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect |
| 12/11/2007 | US7306808 Orientia tsutsugamushi truncated recombinant outer membrane protein (r47) and (r57) vaccines diagnostics and therapeutics for scrub typhus |
| 12/11/2007 | US7306801 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 12/11/2007 | US7306791 Comprising Tumor cytotoxic factor-II or Hepatocyte growth factor as an effective ingredient |
| 12/11/2007 | US7306783 Complexing; drug delivery; in situ imaging; detection apoptosis |
| 12/11/2007 | CA2393271C Retroviral protease inhibiting compounds |
| 12/11/2007 | CA2370202C Gum pad for delivery of medication to mucosal tissues |
| 12/11/2007 | CA2348245C Treatment of rumen acidosis with .alpha.-amylase inhibitors |
| 12/11/2007 | CA2224426C Cis-9,10-octadecenoamidase |
| 12/11/2007 | CA2221865C Bradykinin analogs as selective thrombin inhibitors |
| 12/06/2007 | WO2007140410A2 Low-density lipoprotein receptor 6 (lrp6) as a mammary stem cell marker and related methods |
| 12/06/2007 | WO2007139961A1 Methods of reducing cell death following hypoxia / reoxygenation |
| 12/06/2007 | WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof |
| 12/06/2007 | WO2007139153A1 Function-improving agent for cerebral dysfunction caused by environmental chemical |
| 12/06/2007 | WO2007139150A1 ANTI-INFLUENZA VIRAL AGENT COMPRISING TNF-α INHIBITOR |
| 12/06/2007 | WO2007139128A1 Composition for inhibiting the secretion of creatine phosphokinase |
| 12/06/2007 | WO2007139120A1 AMYLOID-β CLEARANCE ENHANCER |
| 12/06/2007 | WO2007139062A1 Therapeutic agent for obesity, and method for treatment and prevention of obesity |
| 12/06/2007 | WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound |
| 12/06/2007 | WO2007138994A1 Hsp90 inhibitor |
| 12/06/2007 | WO2007138961A1 Prophylactic or therapeutic agent for disorder induced by macrophage migration inhibitory factor |
| 12/06/2007 | WO2007138933A1 Remedy for diabetes |
| 12/06/2007 | WO2007138810A1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 12/06/2007 | WO2007138781A1 Antiviral agent and antibacterial agent |
| 12/06/2007 | WO2007138748A1 Pharmaceutical agent for recovery from fatigue |
| 12/06/2007 | WO2007137342A1 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same |
| 12/06/2007 | WO2007117398A3 Non-peptidic molecules for detecting and treating tumors |
| 12/06/2007 | WO2007025187A3 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 12/06/2007 | WO2006122183A3 Injectable hydrogels and methods of making and using same |
| 12/06/2007 | US20070282126 Novel Crystal Of Triterpene Derivative |
| 12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
| 12/06/2007 | US20070282009 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 12/06/2007 | US20070281994 Use Of Furan Alkyls For A Cellulite Cosmetic Treatment |
| 12/06/2007 | US20070281967 Nuclear Transfer Promoter For Rac Protein And Method Of Screening The Dame |
| 12/06/2007 | US20070281963 tyrosine kinase inhibitors such as 3-amino-2-(2-chloro-5-hydroxyphenyl)-7-(3-morpholin-4-ylpropoxy)-2,5-dihydro-4H-pyrazolo[4,3-c]quinolin-4-one, used as anticarcinogenic or antiproliferative agents |
| 12/06/2007 | US20070281958 Preparation of oxycodone |
| 12/06/2007 | US20070281956 Phenylpyrimidine amines as IgE inhibitors |
| 12/06/2007 | US20070281955 e.g. 3-{5-[2-({(3R)-1-[(4-chlorophenyl)sulfonyl]piperidin-3-yl}amino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl carbamate; antiproliferative, anticarcinogenic agent; cell proliferative disorders |
| 12/06/2007 | US20070281948 Substituted 2-pyridone derivatives, method for their preparation and their use as medicament |
| 12/06/2007 | US20070281935 Use |
| 12/06/2007 | US20070281928 Fused Ring Azadecalin Glucocorticoid Receptor Modulators |
| 12/06/2007 | US20070281919 Aminothiazole Derivatives And Their Use As CRF Receptor Ligands |
| 12/06/2007 | US20070281912 treating with a mixture comprising nomegestrol acetate and estradiol valerate or estradiol; side effect reduction |
| 12/06/2007 | US20070281907 Kinase Inhibitor Phosphonate Conjugates |
| 12/06/2007 | US20070281896 Novel compositions and methods in cancer |
| 12/06/2007 | US20070281888 having an activity of growing vascular endothelial cells, promoting transcription form c-fos promoter, promoting transciption from VEGF promoter and/or an angiogenic activity; a polynucleotide encoding this polypeptide; for treating obstructive arteriosclerosis, peripheral vascular disorder, angina |
| 12/06/2007 | US20070281036 System and method of delivering a desired material to a cell |
| 12/06/2007 | US20070280961 cDNA corresponding to the antigenome of nonsegmented negative strand RNA viruses and process for the production of such viruses |
| 12/06/2007 | US20070280952 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders |
| 12/06/2007 | US20070280940 Tweak as a Therapeutic Target for Treating Central Nervous System Diseases Associated with Cerebral Edema and Cell Death |
| 12/06/2007 | US20070280925 Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases |
| 12/06/2007 | US20070280916 Pharmaceutical Formulations Comprising Paraoxonase |
| 12/06/2007 | US20070280909 Shelf-Stable Product With Living Micro-Organisms |
| 12/06/2007 | US20070280907 Adult bone marrow cell transplantation to testes creation of transdifferentiated testes germ cells, leydig cells and sertoli cells |